Cramer: Be Alert For Buying Opportunities

Make no mistake, not all weakness is a buying opportunity, Cramer warned. President Trump took aim at the drug stocks last week, but only Pfizer (PFE - Get Report) agreed to roll back some drug prices. That will likely leave the rest of the drugmakers vulnerable once Trump gets back to the White House.

Bank of America
For his "Executive Decision" segment, Cramer sat down with Brian Moynihan, chairman and CEO at Bank of America (BAC - Get Report) , to discuss his company's six-cents-a-share earnings beat which included robust loan growth. Moynihan started off by saying that Bank of America's digitization efforts are all about convenience for their customers, helping to produce great results while lowering costs.

Appetite for McCormick
Despite putting up great quarterly results since the acquisition, McCormick's stock failed to get any traction as the negativity swirled. That was until last month, when the company delivered a nine-cents-a-share earnings beat that could not be ignored. Shares vaulted from $105 to $114 in a single day and now trade north of $118.

Enbridge
In his second "Executive Decision" segment, Cramer checked in with Al Monaco, president and CEO of Enbridge (ENB - Get Report) , the oil and gas pipeline company with a 5.8% yield and shares that are up 22% from their April lows. Monaco said he sees huge opportunities for North American natural gas as it begins to gain market share in the global marketplace.

Source: TheStreet

Read more:

• Peloton can collaps by 86% under competitive pressure
• Hong Kong will continue to push down the financial markets!
• S&P on a historic high, analysts expect more gains
• 7 best exchange-traded ETFs for dividends
• Five cannabis stocks under $10 you need to buy